CD8A and neoplasm: In contrast, the less immunogenic B16F10-OVA model did not show significant differences in tumor growth; however, CD39KO mice displayed an increased frequency of antigen-specific, pre-exhausted (PD-1<sup>Int</sup>) CD8<sup>+</sup> T cells, a population recognized as a key target of immunotherapy.